- 期刊
Diffuse Alveolar Damage Associated with Ticlopidine Use: A Case Report
使用Ticlopidine 中發生之瀰漫性肺泡損壞：病例報告
並列摘要
Abstract: Ticlopidine-induced lung disease is rare. A 52-year-old man with acute myocardial infarction developed respiratory distress 2 days after receiving ticlopidine for coronary artery stenting. The dosage of ticlopidine was 500 mg orally followed by maintenance of 250 mg twice daily. Chest radiography revealed bilateral haziness predominantly over upper lung fields. He did not respond to treatment for suspected cardiogenic lung edema and mechanical ventilation was instituted. Open lung biopsy documented diffuse alveolar damage. After discontinuing ticlopidine and treatment with systemic corticosteroid, his pulmonary condition improved gradually. Within 2 weeks, the patient was successfully weaned from the ventilator. Although rare, alveolar damage is a potential side effect of ticlopidine treatment and should be included in the differential diagnoses of heart failure patients taking ticlopidine who respond poorly to optimal therapy.
延伸閱讀
- 羅子涵、陳慧秦、蔡玉琴、劉瑞芳（2022）。除草劑吸入續發性肺泡蛋白沉積症使用葉克膜及全肺灌洗治療：病例報告。呼吸治療，21(1)，75-83。https://doi.org/10.6269/JRT.202201_21(1).0007
- Tsai, M. J., & Chang, S. C. (2009). 支氣管鏡肺葉灌洗術在單側肺泡蛋白質沉著症的治療－病例報告. 胸腔醫學, 24(4), 199-205. https://doi.org/10.29806/TM.200908.0003
- Su, B. H., Hu, P. S., Peng, C. T., & Tsai, C. H. (1998). 以氣管內沖洗及補充肺表面張力素（Surfactant）治療重症胎便吸入症候群. Mid-Taiwan Journal of Medicine, 3(4), 191-197. https://doi.org/10.6558/MTJM.1998.3(4).1
- 劉書呈、涂曦丰、張妤欣（2022）。游離皮瓣術後使用Dextran 40後併發急性肺水腫－二病例報告。臺灣口腔顎面外科學會雜誌，33(3)，194-200。https://www.airitilibrary.com/Article/Detail?DocID=a0000494-202209-202210040024-202210040024-194-200
- Hsu, S. P., Chu, K. A., Wang, H. C., Lin, M. H., & Chang, H. C. (2007). 肺泡蛋白質沉著症接受全肺灌洗術術後併發氣管狹窄－病例報告. 胸腔醫學, 22(5), 313-320. https://doi.org/10.29806/TM.200710.0002